Cisplatin/Durvalumab/Gemcitabine/Tremelimumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, durvalumab, gemcitabine and tremelimumab that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Cisplatin-Durvalumab-Gemcitabine-Tremelimumab - Cisplatin/Durvalumab/Gemcitabine/Tremelimumab - Cisplatin/Durvalumab/Gemcitabine/Tremelimumab-actl - Cisplatin/Imjudo/Gemcitabine/Imfinzi - Imjudo/Imfinzi Plus Cisplatin/Gemcitabine - Tremelimumab/Durvalumab/Gemcitabine/Cisplatin